Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
(Total Views: 387)
Posted On: 03/30/2017 1:30:15 PM
Post# of 30067
Posted By: Bornet
"On March 10, 2017, the Company’s board of directors approved a change in the Company's fiscal year end from January 31 st to December 31 st , effective immediately. The required transition period of February 1, 2016 to December 31, 2016 is included in the financial statements set forth in this report. The Company presently has no revenues and minimal assets, and accordingly, the Company may be deemed to be a shell company. The Company is currently reviewing business opportunities, including the potential to enter into a reverse merger transaction . At the present time, the Company has not yet entered into any agreement for such transaction.

At the present time we have two officers, our Chief Executive Officer Conn Flanigan and our Chief Financial Officer Rongguo (Ronald) Wei. Our board of directors includes Mr. Flanigan and Fai H. Chan, the Chief Executive Officer of Singapore eDevelopment, our largest shareholder. We have no employees as of the date of this Report."

https://www.otcmarkets.com/edgar/GetFilingHtm...D=11962693













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site